Felicitas Kühne
Publications 10
#1Charles Christian Adarkwah (UM: Maastricht University)H-Index: 4
#2Nikita JeganH-Index: 1
Last.Sarah KürwitzH-Index: 1
view all 8 authors...
Background The concept of shared-decision-making is a well-established approach to increase the participation of patients in medical decisions. Using lifetime risk or time-to-event (TTE) formats has been increasingly suggested as they might have advantages, e.g. in younger patients, to better show consequences of unhealthy behaviour. In this study, the most-popular ten-year risk illustration in the decision-aid-software arribaTM (emoticons), is compared within a randomised trial to a new-develop...
#1Beate JahnH-Index: 10
#2Ursula RochauH-Index: 6
Last.Uwe SiebertH-Index: 56
view all 10 authors...
Objectives. Breast cancer is the most common malignancy among women in developed countries. We developed a model (the Oncotyrol breast cancer outcomes model) to evaluate the cost-effectiveness of a 21-gene assay when used in combination with Adjuvant! Online to support personalized decisions about the use of adjuvant chemotherapy. The goal of this study was to perform a cross-model validation. Methods. The Oncotyrol model evaluates the 21-gene assay by simulating a hypothetical cohort of 50-year...
#1Felicity Lamrock ('QUB': Queen's University Belfast)H-Index: 2
#2Karen Cairns ('QUB': Queen's University Belfast)H-Index: 7
Last.Kari Kuulasmaa (National Institute for Health and Welfare)H-Index: 66
view all 12 authors...